Effectiveness of clinical trials published in leading Asian Medical Journal
PUNE: Cancer is one of the most dreaded diseases which requires expensive treatment. But in a ray of hope for oral cancer patients, Dr. Vijay Kanuru, a bio-nano scientist with Oncocur, has developed an advanced cost-effective nanomedicine for the treatment of early-stage oral cancer and oral cancer prevention.
The effectiveness of this medicine – ‘BRECAN’, developed using nano curcumin, was documented during the clinical trials and has been featured by a leading medical journal – Journal of Oral and Maxillofacial Pathology, brought out by the Indian Association of Oral and Maxillofacial Pathology.
This was revealed by Dr. Vijay Kanuru during a Press Conference held in the city.
Dr. Kanuru is an alumnus of SPPU (Savitribai Phule Pune University) and he did his master’s from here before completing his Ph.D. at Cambridge University, UK. He has also studied at Stanford Medical School, USA.
“India has the highest number of oral cancer cases. Oral cancer accounts for 30 percent of all types of cancer in the country, as 20 people per 1 lakh population are affected by oral cancer. Over five people in India die every hour due to oral cancer and hence my goal was to develop an advanced nanomedicine for the prevention of oral cancer,” Dr. Kanuru said.
“There was no nano formulation developed exclusively for oral cancer,” he emphasized.
According to Dr. Vijay Kanuru, the clinical trials were held on 30 patients, who were having an early stage of oral cancer and the results were extremely positive.
“There was a decrease in size of the lesion, number of lesions, downstaging of the disease, and increase in serum Superoxide Dismutase (SOD) levels. The patients also experienced pain relief. It also helped in improving quality of life,” Dr. Vijay Kanuru said, adding the patients, on whom the clinical trial was held, were not given any chemo drugs.
He also said BRECAN treats early-stage cancerous lesions without the use of potent steroids which are harmful.
“It can also prevent relapses and reduces the dependency on toxic chemo and painful radiation therapies during and after the cancer treatments. It is also helpful to prevent relapse of cancer,” Dr. Vijay Kanuru added.
He further said there were no side effects of the medicine, which is extremely cost-effective and is priced at Rs 1,500 for 60 capsules.
